Annual EBITDA
$1.39B$88.72M+6.84%
Summary
- Current Value
- As of today, JAZZ annual EBITDA is $1.39B, up +6.84% on
- Historical Performance
- JAZZ annual EBITDA is up +45.70% over the past 3 years, and up +36.96% over the past 5 years
- All-Time High Comparison
- JAZZ annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- JAZZ annual EBITDA is +6.84% above its 3-year low of $1.30B reached on
- Sector Comparison
- JAZZ annual EBITDA is higher than 94.75% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.39B | +6.8% | +45.7% | +37.0% | +5440.8% | |
| Quarterly EBITDA | $339.76M | -20.1% | +11.2% | +22.4% | +1960.0% | |
| TTM EBITDA | $1.20B | -13.5% | +2.1% | +19.9% | +2177.8% | |
| Price | $169.37 | +38.2% | +6.7% | +4.0% | +757.1% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $4.07B | +6.1% | +31.5% | +88.2% | +3067.8% | |
| Annual EPS | $8.65 | +41.8% | +256.6% | -4.9% | +3898.3% | |
| Annual EBIT | $708.45M | +20.6% | +327.0% | +34.5% | +4347.3% | |
| Annual Net Income | $560.12M | +35.0% | +269.9% | +7.0% | +8293.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.39B | at high | |
| 5Y | $1.39B | at high | |
| All | $1.39B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.30B | +6.8% | |
| 5Y | $951.76M | +45.7% | |
| All | -$122.08M | +1235.9% |
EBITDA History
FAQ
What is the current annual EBITDA of JAZZ?
As of today, JAZZ annual EBITDA is $1.39B
What is 1-year change in JAZZ annual EBITDA?
JAZZ annual EBITDA is up +6.84% year-over-year
What is 3-year change in JAZZ annual EBITDA?
JAZZ annual EBITDA is up +45.70% over the past 3 years
How far is JAZZ annual EBITDA from its all-time high?
JAZZ annual EBITDA is currently at its all-time high
How does JAZZ annual EBITDA rank versus sector peers?
JAZZ annual EBITDA is higher than 94.75% of companies in Healthcare sector
When is JAZZ next annual earnings release?
The next annual earnings release for JAZZ is on
Quarterly EBITDA
$339.76M$53.22M-13.54%
Summary
- Current Value
- As of today, JAZZ quarterly EBITDA is $339.76M, down -13.54% on
- Historical Performance
- JAZZ quarterly EBITDA is down -20.14% year-over-year, and up +11.15% over the past 3 years
- All-Time High Comparison
- JAZZ quarterly EBITDA is currently -20.14% below its historical high of $425.44M set on
- 3-Year Low Comparison
- JAZZ quarterly EBITDA is +211.76% above its 3-year low of $108.98M reached on
- Sector Comparison
- JAZZ quarterly EBITDA is higher than 93.95% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $339.76M | -13.5% | -20.1% | +11.2% | +22.4% | |
| Annual EBITDA | $1.39B | – | +6.8% | +45.7% | +37.0% | |
| TTM EBITDA | $1.20B | -6.7% | -13.5% | +2.1% | +19.9% | |
| Price | $169.37 | +23.3% | +38.2% | +6.7% | +4.0% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $1.13B | +7.7% | +6.7% | +19.7% | +87.4% | |
| Quarterly EPS | $4.08 | +134.8% | +19.9% | +1404.3% | +54.8% | |
| Quarterly EBIT | $161.51M | -26.2% | -37.9% | +3.0% | -21.7% | |
| Quarterly Net Income | $251.41M | +135.0% | +16.9% | +1379.6% | +69.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $392.98M | -13.5% | |
| 3Y | $425.44M | -20.1% | |
| 5Y | $425.44M | -20.1% | |
| All | $425.44M | -20.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $108.98M | +211.8% | |
| 3Y | $108.98M | +211.8% | |
| 5Y | $108.98M | +211.8% | |
| All | -$111.24M | +405.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of JAZZ?
As of today, JAZZ quarterly EBITDA is $339.76M
What is JAZZ quarterly EBITDA most recent change?
JAZZ quarterly EBITDA was down -13.54% on September 30, 2025
What is 1-year change in JAZZ quarterly EBITDA?
JAZZ quarterly EBITDA is down -20.14% year-over-year
How far is JAZZ quarterly EBITDA from its all-time high?
JAZZ quarterly EBITDA is currently -20.14% below its historical high of $425.44M set on September 30, 2024
How does JAZZ quarterly EBITDA rank versus sector peers?
JAZZ quarterly EBITDA is higher than 93.95% of companies in Healthcare sector
When is JAZZ next earnings release?
The next earnings release for JAZZ is on
TTM EBITDA
$1.20B$85.69M-6.66%
Summary
- Current Value
- As of today, JAZZ TTM EBITDA is $1.20B, down -6.66% on
- Historical Performance
- JAZZ TTM EBITDA is down -13.54% year-over-year, and up +2.08% over the past 3 years
- All-Time High Comparison
- JAZZ TTM EBITDA is currently -13.54% below its historical high of $1.39B set on
- 3-Year Low Comparison
- JAZZ TTM EBITDA is +3.20% above its 3-year low of $1.16B reached on
- Sector Comparison
- JAZZ TTM EBITDA is higher than 93.77% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.20B | -6.7% | -13.5% | +2.1% | +19.9% | |
| Annual EBITDA | $1.39B | – | +6.8% | +45.7% | +37.0% | |
| Quarterly EBITDA | $339.76M | -13.5% | -20.1% | +11.2% | +22.4% | |
| Price | $169.37 | +23.3% | +38.2% | +6.7% | +4.0% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $4.16B | +1.7% | +4.1% | +16.0% | +82.4% | |
| TTM EPS | -$6.07 | +10.0% | -187.4% | -1827.0% | -291.9% | |
| TTM EBIT | $515.36M | -16.1% | -30.2% | -2.2% | -16.5% | |
| TTM Net Income | -$368.48M | +9.0% | -179.6% | -1871.9% | -305.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.39B | N/A | -13.4% |
| 3Y | $1.39B | -13.5% | |
| 5Y | $1.39B | -13.5% | |
| All | $1.39B | -13.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.20B | at low | |
| 3Y | $1.16B | +3.2% | |
| 5Y | $943.46M | +27.3% | |
| All | -$165.94M | +823.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of JAZZ?
As of today, JAZZ TTM EBITDA is $1.20B
What is JAZZ TTM EBITDA most recent change?
JAZZ TTM EBITDA was down -6.66% on September 30, 2025
What is 1-year change in JAZZ TTM EBITDA?
JAZZ TTM EBITDA is down -13.54% year-over-year
How far is JAZZ TTM EBITDA from its all-time high?
JAZZ TTM EBITDA is currently -13.54% below its historical high of $1.39B set on September 30, 2024
How does JAZZ TTM EBITDA rank versus sector peers?
JAZZ TTM EBITDA is higher than 93.77% of companies in Healthcare sector
When is JAZZ next earnings release?
The next earnings release for JAZZ is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- JAZZ Official Website www.jazzpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1232524/000123252425000074/0001232524-25-000074-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1232524/000123252425000011/0001232524-25-000011-index.htm
- JAZZ Profile on Yahoo Finance finance.yahoo.com/quote/JAZZ
- JAZZ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/jazz